Literature DB >> 23553379

Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics.

Megan M Clarke1, Michael P Dorsch, Susie Kim, Keith D Aaronson, Todd M Koelling, Barry E Bleske.   

Abstract

STUDY
OBJECTIVES: To identify baseline predictors of worsening renal function (WRF) in an acute decompensated heart failure (ADHF) patient population receiving continuous infusion loop diuretics.
DESIGN: Retrospective observational analysis.
SETTING: Academic tertiary medical center. PATIENTS: A total of 177 patients with ADHF receiving continuous infusion loop diuretics from January 2006 through June 2009.
MEASUREMENTS AND MAIN RESULTS: The mean patient age was 61 years, 63% were male, ~45% were classified as New York Heart Association functional class III, and the median length of loop diuretic infusion was 4 days. Forty-eight patients (27%) developed WRF, and 34 patients (19%) died during hospitalization. Cox regression time-to-event analysis was used to determine the time to WRF based on different demographic and clinical variables. Baseline serum albumin 3 g/dl or less was the only significant predictor of WRF (hazard ratio [HR] 2.87, 95% confidence interval [CI] 1.60-5.16, p=0.0004), which remained significant despite adjustments for other covariates.
CONCLUSION: Serum albumin 3 g/dl or less is a practical baseline characteristic associated with the development of WRF in patients with ADHF receiving continuous infusion loop diuretics.
© 2013 Pharmacotherapy Publications, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553379     DOI: 10.1002/phar.1241

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  Retroelements and formation of chimeric retrogenes.

Authors:  A A Buzdin
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 2.  Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature.

Authors:  R De Vecchis; C Esposito; C Ariano; S Cantatrione
Journal:  Herz       Date:  2014-03-30       Impact factor: 1.443

3.  Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide.

Authors:  Yoichi Takaya; Fumiki Yoshihara; Hiroyuki Yokoyama; Hideaki Kanzaki; Masafumi Kitakaze; Yoichi Goto; Toshihisa Anzai; Satoshi Yasuda; Hisao Ogawa; Yuhei Kawano; Kenji Kangawa
Journal:  Heart Vessels       Date:  2017-02-07       Impact factor: 2.037

4.  Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).

Authors:  Justin L Grodin; Dianne Gallup; Kevin J Anstrom; G Michael Felker; Horng H Chen; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2017-03-29       Impact factor: 2.778

5.  Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF.

Authors:  Justin L Grodin; Anuradha Lala; Susanna R Stevens; Adam D DeVore; Lauren B Cooper; Omar F AbouEzzeddine; Robert J Mentz; John D Groarke; Emer Joyce; Julie L Rosenthal; Justin M Vader; W H Wilson Tang
Journal:  J Card Fail       Date:  2016-02-02       Impact factor: 5.712

6.  Prognostic role of albumin level in heart failure: A systematic review and meta-analysis.

Authors:  Mahmoud El Iskandarani; Bara El Kurdi; Ghulam Murtaza; Timir K Paul; Marwan M Refaat
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

7.  Association of admission vs. nadir serum albumin concentration with short-term treatment outcomes in patients with acute heart failure.

Authors:  Evan J Peterson; Tien M H Ng; Komal A Patel; Mimi Lou; Uri Elkayam
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.